Nerve Repair and Regeneration Market by Product (Neurostimulation and Neuromodulation Devices, External Neurostimulation Devices and Biomaterials), Application (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, and Stem Cell Therapy), End-User (Hospitals & Clinics and Ambulatory Surgery Centres) Geography (North America, Europe, Asia Pacific, and RoW)- Global Opportunity Analysis and Industry Forecast up to 2026
- Report Code : IHR2138712
- Published On: Apr, 2021
- Category : Biotechnology
- Pages : 88
-
Nerves are collective neurons, which help in sending messages from one body part to another part like signals. Injuries can cause damage to nerve cells and may not be able to send signals to and from the brain. Nerve damage can cause due to the pressure, stretching, or cutting of a nerve. Nerve repair and regeneration process can help to restore the nerves to the normal condition. Globally, major factors contributing to the Nerve repair and regeneration market growth include increasing number of nerve injuries, rapidly increasing old population where the nerves are very sensitive in this group as well as the rapidly growing neurological disorders. However, the lack of trained professionals and strict regulations are constraints in the market growth. The Nerve Repair and Regeneration market is predicted to reach $16.89 Billion by 2026 from $8.62 Billion in 2020, at a CAGR of ~11.8% during the forecast period.
The Nerve Repair and Regeneration market is segmented based on product, application, end-user, and geography.
Based on Product:
• Neurostimulation and Neuromodulation Devices
o Internal Neurostimulation Devices
Spinal Cord Stimulation
Deep Brain Stimulation
Vagus Nerve Stimulation
Sacral Nerve Stimulation
Gastric Electrical Stimulation
• External Neurostimulation Devices
o Transcutaneous Electrical Nerve Stimulation
o Transcranial Magnetic Stimulation
• Biomaterials
o Nerve Conduits
o Nerve Protectors
o Nerve Wraps
o Nerve Connectors
Based on Application:
• Neurostimulation and Neuromodulation Surgeries
o Internal Neurostimulation and Neuromodulation Surgeries
o External Neurostimulation and Neuromodulation Surgeries
• Direct Nerve Repair/Neurorrhaphy
o Epineural Repair
o Perineural Repair
o Group Fascicular Repair
• Nerve Grafting
o Autografts
o Allografts
o Xenografts
• Stem Cell Therapy
Based on End User:
• Hospitals & Clinics
• Ambulatory Surgery Centres
Based on Geography:
• North America
• Europe
• Asia Pacific
• Rest of the World
Based on product segment neurostimulation and neuromodulation devices segment accounted the largest share in the nerve repair and regeneration market due to the increasing occurrences of peripheral nerve injuries, advance technology in the nerve repair and regeneration, and the benefits of reimbursement policies are the factors enhancing the market growth.
Further, based on application neurostimulation and neuromodulation segment is expected to have the largest share in the market due to the rapidly increasing neurological disorders such as epilepsy, Alzheimer's disease, and other dementias and growing occurrences of peripheral nerve injuries.
The nerve repair and regeneration market, based on end-users the market is segmented into hospitals and clinics and ambulatory surgery centers. Hospitals segment accounted for the largest share in the market due to the increasing number of nerve repair and nerve surgery procedures in hospitals, increased old population, and well-established healthcare infrastructure.
On the bases of geography, the market is segmented into four regions includes North America, Europe, APAC, and RoW. North America is dominating the market growth due to the increased cases of nerve injuries, well-established healthcare centers in this region, and high investments in the healthcare industry in this region are factors solidifying the growth.
Globally, the nerve repair and regeneration market is expanding due to the increasing neurological disorders; emerging technologies in the field of neurological surgeries, increasing elderly population in all over the world are the factors driving the nerve repair and regeneration market. Emerging countries are expected to be the future markets and give a new opportunity for market growth. Somehow, difficulties may occur in treating the large nerve gaps, and this is the challenge for the market growth.
The key market players in the Nerve Repair and Regeneration market are Livanova, Orthomed, Axogen, Baxter, Integra Lifescience, Abbott Laboratories, Boston Scientific, Nevro, Stryker, Medtronic, Polyganics, and Neuropace.
The constricted regulations and time-consuming approval process are the major challenges in the nerve repair and regeneration market. However, the advanced stem-cell therapy in the nerve the market provides the opportunity for the nerve repair and regeneration market. This report helps to understand the key market trends, market players strategies, and end-user analysis.
● The competitive analysis of the major players enables users to understand the dynamic strategies such as product innovation, partnerships, merger & acquisitions and joint ventures of the key players
● This report also provides the portfolio analysis, capability analysis of the leading players
● Quantitative analysis of the market enables users to understand the actual facts of the market across four major regions
-
With tables and figures helping analyze worldwide Nerve Repair and Regeneration market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.3. PEST Analysis
3.4. Porter Five Forces
3.5. Related Markets
4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis
5. Product: Market Size & Analysis
5.1. Overview
5.2. Neurostimulation and Neuromodulation Devices
5.2.1. Internal Neurostimulation Devices
5.2.1.1. Spinal Cord Stimulation
5.2.1.2. Deep Brain Stimulation
5.2.1.3. Vagus Nerve Stimulation
5.2.1.4. Sacral Nerve Stimulation
5.2.1.5. Gastric Electrical Stimulation
5.2.2. External Neurostimulation Devices
5.2.2.1. Transcutaneous Electrical Nerve Stimulation
5.2.2.2. Transcranial Magnetic Stimulation
5.3. Biomaterials
5.3.1. Nerve Conduits
5.3.2. Nerve Protectors
5.3.3. Nerve Wraps
5.3.4. Nerve Connectors
6. Application: Market Size & Analysis
6.1. Overview
6.2. Neurostimulation and Neuromodulation Surgeries
6.2.1. Internal
6.2.2. External
6.3. Direct Nerve Repair/Neurorrhaphy
6.3.1. Epineural Repair
6.3.2. Perineural Repair
6.3.3. Group Fascicular Repair
6.4. Nerve Grafting
6.4.1. Autografts
6.4.2. Allografts
6.4.3. Xenografts
6.5. Stem Cell Therapy
7. End User: Market Size & Analysis
7.1. Overview
7.2. Hospitals & Clinics
7.3. Ambulatory Surgery Centers
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.3. Mergers and Acquisitions, Legal, Awards, Partnerships
9.4. Product Launches and execution
10. Vendor Profiles
10.1. Axogen
10.1.1. Overview
10.1.2. Product Offerings
10.1.3. Geographic Revenue
10.1.4. Business Units
10.1.5. Developments
10.1.6. Business Strategy
10.2. Baxter
10.2.1. Overview
10.2.2. Product Offerings
10.2.3. Geographic Revenue
10.2.4. Business Units
10.2.5. Developments
10.2.6. Business Strategy
10.3. Boston Scientific
10.3.1. Overview
10.3.2. Product Offerings
10.3.3. Geographic Revenue
10.3.4. Business Units
10.3.5. Developments
10.3.6. Business Strategy
10.4. Livanova
10.4.1. Overview
10.4.2. Product Offerings
10.4.3. Geographic Revenue
10.4.4. Business Units
10.4.5. Developments
10.4.6. Business Strategy
10.5. Integra Lifesciences
10.5.1. Overview
10.5.2. Product Offerings
10.5.3. Geographic Revenue
10.5.4. Business Units
10.5.5. Developments
10.5.6. Business Strategy
10.6. Medtronic
10.6.1. Overview
10.6.2. Product Offerings
10.6.3. Geographic Revenue
10.6.4. Business Units
10.6.5. Developments
10.6.6. Business Strategy
10.7. Abbott Laboratories
10.7.1. Overview
10.7.2. Product Offerings
10.7.3. Geographic Revenue
10.7.4. Business Units
10.7.5. Developments
10.7.6. Business Strategy
10.8. Stryker
10.8.1. Overview
10.8.2. Product Offerings
10.8.3. Geographic Revenue
10.8.4. Business Units
10.8.5. Developments
10.8.6. Business Strategy
10.9. Polyganics
10.9.1. Overview
10.9.2. Product Offerings
10.9.3. Geographic Revenue
10.9.4. Business Units
10.9.5. Developments
10.9.6. Business Strategy
10.10. Nevro
10.10.1. Overview
10.10.2. Product Offerings
10.10.3. Geographic Revenue
10.10.4. Business Units
10.10.5. Developments
10.10.6. Business Strategy
11. Companies to Watch
11.1. Neuropace
11.1.1. Overview
11.1.2. Market
11.1.3. Business Strategy
11.2. Orthomed
11.2.1. Overview
11.2.2. Market
11.2.3. Business Strategy
11.3. Nevro
11.3.1. Overview
11.3.2. Market
11.3.3. Business Strategy
12. Analyst Opinion
13. Annexure
13.1. Report Scope
13.2. Market Definitions
13.3. Research Methodology
13.3.1. Data Collation and In-house Estimation
13.3.2. Market Triangulation
13.3.3. Forecasting
13.4. Report Assumptions
13.5. Declarations
13.6. Stakeholders
13.7. Abbreviations
-
The Nerve Repair and Regeneration Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
New players are entering the Nerve Repair and Regeneration Market, while established companies are changing their business models and strategies. This pattern is likely to continue for the foreseeable future.
Depending upon the type of applications, the Nerve Repair and Regeneration Market has been segmented into
From 2024 to 2029, the Nerve Repair and Regeneration Market is expected to grow at a compound annual growth rate of YY%, reaching a value of USD XXX Million.
The influx of capital into the Nerve Repair and Regeneration Market, as well as the deployment of technologies designed to increase efficiency and yield high volume, are paving the way for promising market opportunities.
The latest version of the Nerve Repair and Regeneration Market study includes a market size breakdown by relevant business segments, applications, and geography, as well as qualitative insights such as Patent Analysis*, Market Entropy, Key Development Activities, Market Dynamics, PEST and PORTER models, and more.
